Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.41 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.40 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19712605 | 0.94 | LPAR3 (0.60) | LPAR3LPAR1LPAR2CYP3A4FDPS | |
| SCHEMBL19712767 | 0.88 | LPAR3 (0.41) | LPAR3LPAR1LPAR2FDPSS1PR1 | |
| SCHEMBL2228657 | 0.87 | FDPS (0.50) | LPAR3LPAR1LPAR2CYP3A4FDPS | |
| Chloromethane SCHEMBL11360800 | 0.86 | CYP3A4 (0.58) | LPAR3LPAR1LPAR2CYP3A4FDPS | |
| SCHEMBL15389152 | 0.85 | CYP3A4 (0.64) | LPAR3LPAR1LPAR2CYP3A4P2RY10 | |
| SCHEMBL29177519 | 0.85 | CYP3A4 (0.64) | LPAR3LPAR1LPAR2CYP3A4P2RY10 | |
| SCHEMBL26559 | 0.85 | CYP3A4 (0.64) | LPAR3LPAR1LPAR2CYP3A4P2RY10 | |
| SCHEMBL11677508 | 0.83 | CYP3A4 (0.61) | LPAR3LPAR1LPAR2CYP3A4P2RY10 | |
| Ammonia Solution, Strong SCHEMBL5519376 | 0.83 | CYP3A4 (0.61) | LPAR3LPAR1LPAR2CYP3A4P2RY10 | |
| SCHEMBL150664 | 0.83 | CYP3A4 (0.61) | LPAR3LPAR1LPAR2CYP3A4P2RY10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3275039-B1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF CORP (US) | 2025-08-27 | — | — | EP | claimed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | claimed |
| CN-107615556-B | Electrolyte and metal hydride battery | 巴斯夫公司 | 2021-11-02 | — | — | CN | claimed |
| CN-107004912-B | Electrolyte and metal hydride battery | 巴斯夫公司 | 2021-07-30 | — | — | CN | claimed |
| EP-3292578-B1 | ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS | BASF CORP (US) | 2021-02-24 | — | — | EP | claimed |
| US-10587012-B2 | Electrolyte compositions comprising ionic liquids and metal hydride batteries comprising same | BASF CORPORATION (US) | 2020-03-10 | — | — | US | claimed |
| US-10243240-B2 | Electrolytes and metal hydride batteries | BASF CORPORATION (US) | 2019-03-26 | — | — | US | claimed |
| EP-3275039-A1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF Corporation (US) | 2018-01-31 | — | — | EP | claimed |
| EP-3218955-A1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF Corporation (US) | 2017-09-20 | — | — | EP | claimed |
| US-20160367462-A1 | METHOD OF TREATING KERATIN MATTER BY FORMING AN IONIC LIQUID | OREAL (FR) | 2016-12-22 | — | — | US | claimed |
| US-20160365228-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION | 2016-12-15 | — | — | US | claimed |
| US-20160329560-A1 | Electrochemical Hydrogen Storage Electrodes and Cells | BASF CORPORATION (US) | 2016-11-10 | — | — | US | claimed |
| US-20160285130-A1 | Electrolytes and Metal Hydride Batteries | U.S. DEPARTMENT OF ENERGY | 2016-09-29 | — | — | US | claimed |
| US-9449797-B2 | Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface | LAM RESEARCH CORPORATION (US) | 2016-09-20 | — | — | US | claimed |
| US-20160141726-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | claimed |
| US-20160141727-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| EP-3275039-B1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF CORP (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2012078783-A2 | IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS | TEXAS STATE UNIVERSITY-SAN MARCOS (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2011091131-A2 | ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160367462-A1 | METHOD OF TREATING KERATIN MATTER BY FORMING AN IONIC LIQUID | KRT18, BROX, ZYX | LPAR3 2226/4885LPAR1 2769/4885LPAR2 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.